Logo Image
News|Articles|June 5, 2026

5 Notable Oncology FDA Approvals Granted in May

Fact checked by: Laura Joszt, MA

FDA decisions in May 2026 included 5 major oncology approvals, including first-in-class therapies for breast cancer, AML, MCL, and NMIBC.

May was an active month for oncology drug development, with the FDA issuing 5 notable approvals that expand treatment options across breast cancer, acute myeloid leukemia (AML), mantle cell lymphoma (MCL), and non–muscle-invasive bladder cancer (NMIBC).